Results 101 to 110 of about 320,605 (196)

Phase II Study of Posttransplant Cyclophosphamide‐Based Graft‐Versus‐Host Disease Prophylaxis After HLA‐Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort

open access: yesAmerican Journal of Hematology, Volume 101, Issue 11, Page 2827-2835, November 2026.
ABSTRACT Posttransplant cyclophosphamide (PTCy) to prevent graft‐versus‐host disease (GVHD) improves outcomes in recipients of HLA mismatched unrelated donor (MMUD) allogeneic hematopoietic cell transplantation (allo HCT). Outcomes of MMUD HCT using PTCy in patients requiring reduced intensity or non‐myeloablative conditioning (RIC/NMA) are not well ...
Brian C. Shaffer   +38 more
wiley   +1 more source

Enfermedades infecciosas: Herpes simple

open access: yesRevista de Medicina y Cine / Journal of Medicine and Movies, 2007
Es indudable el poder del cine para transmitir informaciones, para provocar emociones y para estimular la empatía con los personajes y sus situaciones. Por ese motivo se propone la utilización de películas con protagonistas con discapacidad para favorecer la “visibilidad”, la normalización y el acercamiento a la realidad y a la situación de las ...
García Sánchez, José Elías   +2 more
openaire   +3 more sources

Identifying Systemic Lupus Erythematosus From Serum Proteomic Profiles Using Machine Learning and Genetic Risk Stratification

open access: yesArthritis &Rheumatology, Volume 78, Issue 11, Page 2280-2291, November 2026.
Objective Proteome‐wide risk models for lupus remain underexplored. We developed classification models to identify lupus from serum proteomic profiles. Methods Patients with lupus and individuals with other autoimmune diseases in the UK Biobank were included.
Mehmet Hocaoǧlu   +2 more
wiley   +1 more source

Patterns of immune recovery in people living with HIV who initiated antiretroviral therapy as late presenters

open access: yesBMC Infectious Diseases
Background Some people living with HIV-1 (PWH) do not reconstitute their CD4 + T cell counts despite complete inhibition of HIV-1 replication on antiretroviral therapy (AR); these are known as immunological nonresponders (INR).
Sandra Pinto-Cardoso   +5 more
doaj   +1 more source

Brucelosis: Enfermedad Infecciosa

open access: yes, 2018
The objective of this article is to know the epidemiology and the main clinical manifestations and the diagnostic methods and treatment of the infectious disease produced by Brucella. It has a chronic course that affects both man and animals whether domestic, wildlife or marine mammals.
López Cameselle, Begoña   +3 more
openaire   +1 more source

Nanopartículas bio-inspiradas para el tratamiento de enfermedades infecciosas

open access: yes, 2021
Las nanopartículas suponen un nuevo avance en el tratamiento de enfermedades infecciosas, de especial importancia son aquellas que logran imitar las características de los microorganismos patógenos, ya que son las que mayor respuesta inmunológica ...
Denche Mangas, Samuel
core  

Empirical PK/PD Model for Differentiating Intrinsic Dosing Rules by Therapeutic Indication With Relevance for HIV‐1 Latency Reversal

open access: yesClinical Pharmacology &Therapeutics, Volume 120, Issue 5, Page 1414-1426, November 2026.
Romidepsin (RMD), an FDA‐approved histone deacetylase inhibitor for treating cancer, demonstrates potent latency‐reversing activity in vitro but has yielded suboptimal outcomes in kick‐and‐kill HIV‐cure trials when administered as a 5 mg/m2 infusion.
Lauren A. R. Tompkins   +7 more
wiley   +1 more source

Zoonotic rat hepatitis E virus infection in pigs: farm prevalence and public health relevance

open access: yesPorcine Health Management
Rat hepatitis E virus (ratHEV) is an emerging zoonotic pathogen causing acute and chronic hepatitis, with zoonotic transmission pathways that remain unclear.
Javier Caballero-Gómez   +8 more
doaj   +1 more source

Heparan Sulfate Differentially Regulates Fibroblast Binding by Extracellular Vesicles and Human Cytomegalovirus

open access: yesJournal of Extracellular Vesicles, Volume 15, Issue 11, November 2026.
A model of EV and HCMV interactions with the fibroblast extracellular matrix. Heparan sulfate inhibits interactions between EVs and fibroblast cells bi‐directionally, while serving as the major cell attachment target for human cytomegalovirus (HCMV). EVs instead interact with collagen and fibronectin to facilitate fibroblast binding.
Vladimir Bokun   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy